ARWR

Arrowhead Pharmaceuticals (ARWR)

About Arrowhead Pharmaceuticals (ARWR)

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Details

Daily high

$61.79

Daily low

$57.33

Price at open

52 Week High

$76.76

52 Week Low

$9.57

Market cap

8.4B

Dividend yield

0.00%

Volume

1,190

Avg. volume

2.4M

P/E ratio

38.89

Arrowhead Pharmaceuticals News